Datar Cancer Genetics


We have conducted robust clinical studies to establish the performance of Cancertrack™.

Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors.

Author: Crook T
Datar Cancer Genetics
Published Date: Nov 10, 2020

Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors

Author: Akolkar D
Datar Cancer Genetics
Published Date: Feb 8, 2021

Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC.

Author: Ranade A
Datar Cancer Genetics
Published Date: July 5, 2019

More publications and abstracts

To know more about Publications and Abstracts, please click here

Request a Call Back

Want us to call you back to discuss more? Please leave your name and phone number and we’ll get back to you soon.